Clinical Trial Update: Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase 1 inpatient feasibility study evaluating Tandem's predictive low glucose suspend feature in an insulin pump for pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus

Drugs mentioned

• t:slim X2 Insulin Pump with Predictive Low Glucose Suspend (insulin pump with predictive low glucose suspend)

Snippet

Sponsor: Tandem Diabetes Care, Inc. | Conditions: Diabetes Mellitus, Type 1 Diabetes | Phase 1 | Status: COMPLETED